When we knocked down SORL1 expression in the KRCH31 cells by stably expressing SORL1-targeting shRNA, tumor growth was significantly suppressed in comparison to the tumors formed by the control KRCH31 cells (Figure 5A,B). The gene discussed is SORL1; the disease is neoplasm.